Skip to main content
    E

    Enveric Biosciences Inc (ENVB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.41
    -0.03 (-2.08%)

    Market Cap: $6.45M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Enveric Biosciences Inc (ENVB) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Enveric Biosciences (ENVB) has a latest price of $1.41 on Nov 17, 2026, 89.4% below its 52-week high of $13.25. Its price fell 73.3% over the past 12 months. The month-end price fell 100.0% since Dec 2016, a compound annual decline of 75.5%.

    Price Chart

    From Dec 2016 to Oct 2026, its highest month-end close was $2,024,797.93 in Jun 2017 and its lowest $1.37 in Aug 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ENVB with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ENVB.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 7.6%, and over 6 months it fell 33.2%. The month-end price fell 99.5% over the 3 years through Oct 2026, a compound annual decline of 83.4%.

    PeriodChange
    1 month+1.4%
    3 months+7.6%
    6 months-33.2%
    12 months-73.3%
    12 months, with dividends-73.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-99.5%-83.4%
    5 years-100.0%-84.5%
    Since Dec 2016-100.0%-75.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price fell 34.5%, and its weakest was 2022, when it fell 95.5%.

    YearCloseChange
    2026 through Oct 2026$1.43-60.6%
    2025$3.63-94.4%
    2024$64.51-72.4%
    2023$233.98-37.5%
    2022$374.36-95.5%
    2021$8,369.16-37.2%
    2020$13,318.67-34.5%
    2019$20,337.97-48.2%
    2018$39,236.08-94.4%
    2017$697,430.40-52.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 4.0% below its 50-day average of $1.47 and 25.0% below its 200-day average of $1.88.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.41
    52-week high$13.25-89.4%
    52-week low$1.17+20.5%
    50-day average$1.47-4.0%
    200-day average$1.88-25.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.6%.

    MeasureValue
    1-year beta0.77
    Largest fall, 1 year-87.7%
    Largest fall, 3 years-99.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ENVB

    What is ENVB's 1-year price change?

    Enveric Biosciences's price fell 73.3% over the past 12 months. With dividends included, the 12-month total return was -73.3%.

    What is ENVB's 5-year price change?

    Enveric Biosciences's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 84.5%. These figures leave out dividends.

    What is ENVB's 52-week high and low?

    Enveric Biosciences's 52-week high is $13.25 and its 52-week low is $1.17. Its latest price of $1.41 on Nov 17, 2026 is 89.4% below the high.

    What is ENVB's beta?

    Enveric Biosciences's 1-year beta against the S&P 500 is 0.77, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 87.7%.

    Is the ENVB chart free?

    Yes. Advanced Charting for ENVB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.